Justices Mull Biosimilar Duties At Amgen-Sandoz Arguments
The U.S. Supreme Court on Wednesday appeared torn on how to resolve a high-stakes fight between Amgen and Sandoz, with justices expressing uncertainty about how to interpret the legal obligations of...To view the full article, register now.
Already a subscriber? Click here to view full article